ImmunologybioRxivPreprint
Early immunomodulatory program triggered by pro-tolerogenic Bifidobacterium pseudolongum drives cardiac transplant outcomes
S. J. Gavzy, A. Kensiski, V. Saxena…·J. S. Bromberg
This study identifies Bifidobacterium pseudolongum as inducing an early anti-inflammatory response that influences cardiac transplant outcomes.
DOI 10.1101/2022.10.13.511915